LEADER 01533nam  2200337   450 
001 9910688434903321
005 20230701210730.0
035   $a(CKB)5400000000040560
035   $a(NjHacI)995400000000040560
035   $a(EXLCZ)995400000000040560
100   $a20230701d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMesothelioma /$fedited by Sonia Macia?
210  1$aLondon, England :$cIntechOpen,$d2020.
215   $a1 online resource (118 pages)
311   $a1-83968-156-X 
330   $aMesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact.
606   $aMesothelioma
615  0$aMesothelioma.
676   $a616.99424
702   $aMacia?$b Sonia
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688434903321
996   $aMesothelioma$91737428
997   $aUNINA